Pannexin-1 modulates short-term synaptic plasticity by facilitating endocannabinoid transport

Simple item page
atmire.migration.oldid5905
dc.contributor.advisorThompson, Roger
dc.contributor.authorBialecki, Jennifer
dc.contributor.committeememberBains, Jaideep
dc.contributor.committeememberHill, Matthew
dc.date.accessioned2017-08-31T15:33:06Z
dc.date.available2017-08-31T15:33:06Z
dc.date.issued2017
dc.date.submitted2017en
dc.description.abstractPannexin-1 (Panx1) is a large pore ion/metabolite channel that is permeable to various molecules, ions, ATP, signaling lipids, and fluorescent dyes. To date, Panx1 has been implicated in many pathological conditions including ischemia, epilepsy, cancer, and inflammation. Ascribing a physiological function for these channels in the brain remains elusive outside of reported involvement in modulating synaptic plasticity in the form of long-term potentiation and long-term depression. The mechanisms by which Panx1 contributes to synaptic physiology are largely unknown. Its high expression in many brain regions (including the hippocampus), postsynaptic localization, ability to release ATP, and coupling to glutamate- sensitive NMDAR receptors make Panx1 a great candidate for altering neurotransmission. As such, this thesis explores the role of Panx1 in synaptic plasticity and its underlying signaling mechanisms. My overarching hypothesis is that Panx1 function is critical in maintaining homeostatic neural signaling and that interruption of Panx1 function can result in pathological outcomes. Here I show that inhibition of Panx1 alters neurotransmission in the hippocampus at both inhibitory and excitatory synapses due to its actions as a transporter of the endocannabinoid/ endovanilloid, anandamide (AEA). Regulation of synaptic AEA concentrations is critical to homeostatic control of neurotransmitter release since AEA can act both at CB1Rs, to depress neurotransmission, and TRPV1 channels, to enhance glutamate release. I demonstrate that Panx1 can permeate AEA and alter synaptic AEA concentration, which results in interruption of canonical AEA signaling at CB1Rs. In vivo, this change in AEA concentration leads to neuronal hyper-excitability demonstrated as a heightened rate of seizure susceptibility. In conclusion, the research in this thesis provides a novel role of Panx1 as a transporter of AEA, which may have broad implications in several disease states where AEA dysregulation contributes to pathophysiology.en_US
dc.identifier.citationBialecki, J. (2017). Pannexin-1 modulates short-term synaptic plasticity by facilitating endocannabinoid transport (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/27251en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/27251
dc.identifier.urihttp://hdl.handle.net/11023/4057
dc.language.isoeng
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectNeuroscience
dc.subject.otherPannexin
dc.subject.otherEndocannabinoids
dc.subject.otherTPRV1
dc.titlePannexin-1 modulates short-term synaptic plasticity by facilitating endocannabinoid transport
dc.typedoctoral thesis
thesis.degree.disciplineNeuroscience
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.item.requestcopytrue
Files
Collections
Open Theses and Dissertations